Correction Volume 17, Issue 8 pp 2240
Correction for: Posttranscriptional regulation of AKT by circular RNA angiomotin-like 1 mediates chemoresistance against paclitaxel in breast cancer cells
- 1 Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada
- 2 Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China
- 3 The First Hospital, Jilin University, Jilin, China
- 4 Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada
Received: June 4, 2025 Accepted: August 28, 2025 Published: August 31, 2025
https://doi.org/10.18632/aging.206315How to Cite
Copyright: © 2025 Ma et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article has been corrected: The authors have requested a replacement for Figure 4D. A representative image of the si-circAMOTL1 Control sample in Figure 4D was mistakenly mixed up. The correct panel has now been prepared with the si-circAMOTL1 Control image from the original set of experiments. This alteration does not affect the results or conclusions of this work.
The correct Figures 4D is presented below:
Figure 4. Effect of circAMOTL1 siRNA on PAX treatment. MDA-MB-231 cells transfected with negative control or circAMOTL1 siRNA (si-circAMOTL1) were treated with 1 μg/ml PAX for 24 hours. … ((D) Cell invasive ability upon PAX treatment was measured with Matrigel invasion assay. Experiments were performed in triplicate. **p < 0.01 compared to untreated negative control. ##p < 0.01 compared to untreated si-circAMOTL1.
Abbreviations
DMEM: Dulbecco’s modified Eagle’s medium; FBS: fetal bovine serum; GFP: green fluorescent protein.